Furthermore, the figure highlighted a notable trend that initial approvals tended to be associated with a more extensive array of PMRs compared to approvals for expanding indications.
← all excerpts
Analysis of post-marketing requirements for oncology drug conditional approvals in the United States and China.
1
—
—